Jamie Dananberg - Dec 14, 2022 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Medical Officer
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Jamie Dananberg
Stock symbol
UBX
Transactions as of
Dec 14, 2022
Transactions value $
-$2,896
Form type
4
Date filed
12/15/2022, 03:44 PM
Previous filing
Nov 21, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale -$2.9K -1.02K -1.54% $2.85 65.1K Dec 14, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.
F3 Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected by the Issuer on October 19, 2022, which was exempt from reporting pursuant to Rule 16a-9.